Dirk M. Hermann is a German neurologist and medical scientist whose work focuses on vascular neurology, dementia, and aging disorders. His experimental and clinical research centers on ischemic stroke, the brain microenvironment, the blood-brain barrier, and neurovascular remodeling processes.

Born in 1968, Hermann completed his medical education at the University of Gießen in Germany (1994). He earned his medical doctorate from the same university (1995). He continued his postdoctoral research at the Max Planck Institutes in Munich and Cologne. He completed his clinical neurology residency at the hospitals of the University of Tübingen and the University of Zurich. He obtained his habilitation degree from the University of Tübingen in 2002.

From 1995 to 1998, Hermann worked as a researcher at the Max Planck Institute for Neurological Research in Cologne. From 1998 to 2001, he served as a resident physician in the Department of Neurology at the University of Tübingen. Between 2002 and 2007, he worked as an associate professor at the University Hospital Zurich.

Since 2008, he has been a full professor at the Medical Faculty of the University of Duisburg-Essen, leading the Department of Vascular Neurology, Dementia and Aging Disorders at the Essen University Hospital.

Hermann’s research aims to understand the structural and molecular changes that occur in brain tissue following ischemic stroke. His work particularly focuses on:

• The “gatekeeping” proteins of the blood-brain barrier that regulate drug access to brain tissue,
• The remodeling of the neurovascular unit after ischemic injury,
• Angiogenesis, neurogenesis, and brain plasticity,
• The role of extracellular vesicles secreted by mesenchymal stem cells in post-stroke recovery processes.

His demonstration in experimental models that drug entry into the ischemic brain is actively restricted has provided fundamental insights into the limitations of pharmacological stroke therapies.

Hermann leads the NeuroScienceLab research group at Essen University Hospital. The group investigates molecular signaling pathways, cellular remodeling processes, and intercellular communication mechanisms using in vivo and in vitro experimental stroke models. These studies are supported within the framework of the Stem Cell Network.NRW.

He is also a member of the Zentrum für Medizinische Biotechnologie (ZMB), where he plays an active role in programs focused on vascular neurology and aging research.

Hermann is the author of numerous publications in international journals including The Lancet Neurology, Brain, Nature Communications, Acta Neuropathologica, and Science Signaling. His work has been widely cited, particularly in the fields of ischemic stroke, neuroprotection, and neurovascular remodeling. His research has made significant contributions to bridging the gap between basic science and clinical applications.

• Baasch-Medicus Prize (2005), Swiss Neurological Society
• Ellermann Prize (2007), Swiss Neurological Society
• Felgenhauer Prize (2018), German Neurological Society
• TÜBA International Academy Award – Health and Life Sciences (2025), for his groundbreaking work revealing the critical role of the blood-brain barrier in neurological and pharmacological contexts
• Honorary Professorship, Jilin University (2025)

Dirk M. Hermann’s research has demonstrated that post-stroke recovery cannot be understood solely through neuronal mechanisms but requires an integrated perspective encompassing vascular, immune, and cellular communication networks. This holistic approach has advanced the development of translational research in modern neurology and provided a critical framework for translating experimental findings into clinical practice.